Billionaires Holding KMDA

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.07
    Yield

  • 32.2M
    Shares Outstanding

  • 209.59M
    Market Cap

News & Insights

ABOUT

KMDA

Kamada Ltd. develops, produces, and markets specialty plasma-derived protein therapeutics. It operates through two segments, Proprietary Products and Distribution. The company’s respiratory products include Glassia used in augmentation and maintenance therapy in adults with emphysema due to conge...

Procter & Gamble Co.'s Worst Moves in 2016

NEWS

US STOCKS-Wall St set to open flat as investors test rally

READ MORE